Beyond the injection: Microbiome, GLP-1 and the new reality of weight management

GLP-1 therapies are reshaping weight management but what role does the microbiome play in optimising outcomes? This session explores how probiotics and prebiotics may complement GLP-1–driven pathways in metabolic regulation and appetite control. Moving beyond mechanisms, it brings in the consumer reality: what people actually experience while on GLP-1 medications, and what this means for product development. Industry-relevant insights will highlight opportunities, limitations, and unmet needs, while identifying key knowledge gaps and priority research questions to guide innovation in nutrition solutions aligned with this rapidly evolving landscape.

Association Partner: ILSI Europe

This session will be recorded on site and will be made available for on-demand viewing from 11th May till 26th June 2026.